Statistics
Publications
9
Citations
408
H-Index
9
Active since
1998
Affiliations
Morten Schlein is an author at Novo Nordisk (Denmark) specializing in medicine, diabetes, and biochemistry.
Publications per year
1998–2024
9
9
Development of Cagrilintide, a Long-Acting Amylin Analogue
Thomas Kruse, Jakob Lerche Hansen, Kirsten Dahl et al. · Journal of Medicinal Chemistry · 2021 · 107 citations
HRT, a Novel Zinc Finger, Transcriptional Repressor from Barley
Dora Raventós, Karen Skriver, Morten Schlein et al. · Journal of Biological Chemistry · 1998 · 90 citations · Full text
1–5 of 9